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Abstract
Background: Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) allows rapid and
reliable identification of microorganisms, particularly clinically important pathogens.
Methodology/Principal Findings: We compared the identification efficiency of MALDI-TOF MS with that of PhoenixH, APIH
and 16S ribosomal DNA sequence analysis on 1,019 strains obtained from routine diagnostics. Further, we determined the
agreement of MALDI-TOF MS identifications as compared to 16S gene sequencing for additional 545 strains belonging to
species of Enterococcus, Gardnerella, Staphylococcus, and Streptococcus. For 94.7% of the isolates MALDI-TOF MS results were
identical with those obtained with conventional systems. 16S sequencing confirmed MALDI-TOF MS identification in 63% of
the discordant results. Agreement of identification of Gardnerella, Enterococcus, Streptococcus and Staphylococcus species
between MALDI-TOF MS and traditional method was high (Crohn’s kappa values: 0.9 to 0.93).
Conclusions/Significance: MALDI-TOF MS represents a rapid, reliable and cost-effective identification technique for
clinically relevant bacteria.
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Introduction
Matrix-assisted laser desorption ionization-time of flight mass
spectrometry (MALDI-TOF MS) is rapidly attracting the interest
of microbiologists working in the routine labs, because of its
powerful features that allow rapid and reliable identification of
microorganisms.
Standardized test systems such as APIH and VITEKH 2
(bioMe ´rieux), or PHOENIXH (BD Diagnostics), complemented
by traditional culture and microscopy methods, have so far been
used in routine labs for the rapid identification of clinical
microorganisms. With the introduction of these methods, the
average time needed for a reliable and validated identification
ranged from 6 h to 18 h and in the last few years, sequence
analysis of small-subunit rRNAs or selected genes by PCR
methods has complemented the biochemical methods, additionally
decreasing throughput time and becoming in several cases the gold
standard [1].
The recent developments of MALDI-TOF MS are rapidly
changing the routine diagnostics scene. MALDI-TOF MS is a
powerful method to detect and identify proteins by molecular
weight determination of individual, specific fragments [2]. The
method is accurate and easy to use, allowing quick determination of
molecular weights of proteins with minimal sample requirements.
MALDI-TOF MS is now widely used for the identification and
characterization of clinically important microorganisms [3]. The
currently available identification databases target the identification
of human pathogens [4] and MALDI-TOF MS represents a valid
and rapid alternative to conventional methods of identification
and classification of human pathogens in microbiology.
Traditionally, validation of a new identification system to be
introduced in routine diagnostics consists of running parallel
identifications of a large number of isolates using the new method
concomitantly with set standards.
In this study we compared the identification efficiency of
MALDI-TOF MS with that of PhoenixH, APIH and 16S ribosomal
DNA sequence analysis. In a first step we analyzed 1,019 strains
obtained sequentially during three months from our routine
diagnostic laboratory. In a second step, we studied in more detail
545 isolates of species belonging to the genera Enterococcus,
Gardnerella, Staphylococcus, and Streptococcus and determined the
agreement (and, when possible, efficiency, sensitivity and specific-
ity) of the MALDI-TOF MS identifications as compared to 16S
gene sequencing as the gold standard.
Results
In a first step we analysed 1,019 strains obtained from the routine
diagnostic lab. The results are described in Fig. 1. For 965 isolates
(94.7%) the results of MALDI-TOF MS were identical with those
obtained with the BD PHOENIX system and the confidence level of
the MALDI-TOF MS identification was almost 100% for
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confirmed MALDI-TOF MS identification in63%of the discordant
results. Overall, therefore, MALDI-TOF was able to identify
correctly more than 98% of the isolates tested. Table 2 reports the
specificity, sensitivity, PPV, NPV and efficiency values of the
MALDI-TOF MS identification, compared to the classical methods,
for those bacterial species for which we could analyse at least 15
isolates. With the exception of Enterobacter cloacae and Klebsiella oxytoca,
for which the sensitivity values for identifications at the confidence
level of at least 90% are relatively low, MALDI-TOF MS hasa quite
high efficiency of identification. In most cases these values are still
even if the limit of acceptance of the confidence level for correct
identification by MALDI-TOF MS is set at 99.9% (Table 2).
We analysed separately 76 isolates of Gardnerella,5 0o f
Enterococcus, and 76 of Streptococcus (mainly S. agalactiae and S.
pneumoniae) by MALDI-TOF MS, API/PHOENIX and 16S
sequencing. The results are described in Table 3.
For Gardnerella spp., the %AI was almost 100%. Very good
concordance between 16S sequencing and MALDI-TOF MS was
also observed for Enterococcus faecalis and E. faecium, for which the
concordance was 100%. Results for E. gallinarum were not
particularly good (44.4%), but the number of isolates investigated
(9) was low. MALDI-TOF MS showed a fair performance also
with Streptococcus spp., with quite high sensitivity and specificity
values for S. agalactiae and S. pneumoniae (Table 4).
In a separate experiment we evaluated the efficiency of
MALDI-TOF MS in the identification of Staphylococcus spp. We
considered a sample of 343 staphylococci belonging to 17 species
(S. aureus, S. auricularis, S. capitis, S. carnosus, S. cohnii, S. epidermidis, S.
equorum, S. haemolyticus, S. hominis, S. lugdunensis, S. pasteuri, S.
saprophyticus, S. schleiferi, S. sciuri, S. simulans, S. warneri, S. xylosus) and
we computed sensitivity, specificity, PPV and NPV values for the
four most commonly isolated taxa in our routine laboratory (S.
aureus, S. epidermidis, S. hominis, and S. haemolyticus) as well as the
overall %AI for all species. The outcome of the identification by
MALDI-TOF MS was compared to that obtained by 16S
sequencing, which for the purpose of this work was considered
the gold standard, and other methods (APIH, PHOENIXH)
currently used in our laboratory.
Results are presented in Figure 2, Figure 3 and Figure 4. For the
four species considered, MALDI-TOF MS was at least as good as
the other methods in identifying the species studied, and mostly
the sensitivity, specificity, PPV and NPV values were trend-wise,
albeit not statistically significantly superior to those obtained for
the other methods. The identification agreement between
MALDI-TOF MS and the gold standard used, as represented
by the Crohn’s kappa values, ranged between 0.9 and 0.93,
indicating an almost perfect agreement. The identification
Figure 1. Results of the validation analysis with all isolates.
doi:10.1371/journal.pone.0016424.g001
Table 1. Genera of bacteria studied in the first validation
step.
Genus No. of isolates
Acinetobacter 22
Citrobacter 19
Enterobacter 59
Enterococcus 39
Escherichia 293
Klebsiella 76
Morganella 15
Proteus 85
Pseudomonas 125
Serratia 23
Staphylococcus 182
Stenotrophomonas 33
Streptococcus 21
Others* 27
Total isolates 1019
*includes Aerococcus (1), Aeromonas (3), Alcaligenes (2), Bacillus (1),
Chryseobacterium (2), Corynebacterium (3), Delftia (1), Hafnia (3), Micrococcus
(2), Pasteurella (3), Providencia (2), Raoultella (1), Shewanella (1), Vibrio (1).
doi:10.1371/journal.pone.0016424.t001
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sample investigated was 88.5%.
Discussion
In this study, MALDI-TOF MS has proven to be a fast,
accurate and reliable technique for the identification of clinically
relevant bacteria. We have observed an almost perfect agreement
between identifications obtained by MALDI-TOF MS and those
provided by conventional, biochemical methods. When discordant
results among mass spectrometry and biochemical methods were
observed, sequencing most often confirmed MALDI-TOF MS
identification.
Identification of Gardnerella species by MALDI-TOF MS has
proven to be reliable, needing no additional confirmations by
other methods. The same applied to E. faecium and E. faecalis, both
regularly identified by MALDI-TOF MS at confidence levels of
almost 100% and with a %AI with 16S sequencing of 100%. We
were not able to study enough samples of E. caselliflavus and E.
gallinarum to report reliable values for MALDI-TOF MS
identification of these two species; nevertheless, our present daily
experience places MALDI-TOF MS reliability at least at the same
level as PHOENIXH or APIH (data not shown).
Streptococcus species are notoriously difficult to be identified and
often 16S sequence data are not informative enough to distinguish
species. Glazunova et al. [5] have produced phylogenies of this
genus inferred from rpoB, sodA, gyrB and groEL sequence
comparisons that were more discriminative than those derived
from 16S rRNA. This would explain the rather low %AI (71.4%)
observed for Streptococcus spp. other than S. agalactiae and S.
pneumoniae. MALDI-TOF MS, however, provides reliable identifi-
cation ofspeciesbelongingtotheviridans[6]andmutanscomplex [7];
in the latter case MALDI-TOF MS was useful also for
differentiation at the subspecies level. For group A Streptococcus (S.
pyogenes), MALDI-TOF MS was able to distinguish isolates from
cases of necrotizing fasciitis from those associated with non-invasive
infections, despite they shared the same emm type [8]. Additional
workisneededforspecies inthis genus, however,forwhicha careful
analysis of regional strains could also be very important. For
Streptococcus and Staphylococcus species we have observed regional
Table 2. Sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV) and efficiency of the MALDI-TOF
MS identification of selected species as compared to APIH and PHOENIXH.
N Sensitivity Specificity PPV NPV Sensitivity Specificity PPV NPV Efficiency
(.90) (.90) (99.9) (99.9)
Acinetobacter baumanii 16 87.5 100 100 99.8 81.25 100 100 99.7 93.7
Enterobacter aerogenes 16 93.75 100 100 99.9 93.75 100 100 99.9 100
Enterobacter cloacae 36 69.44 100 100 98.9 30.56 100 100 97.5 97.2
Escherichia coli 294 95.58 100 100 98.2 90.82 100 100 96.4 98.6
Klebsiella oxytoca 24 79.17 100 100 99.5 62.5 100 100 99.1 91.6
Klebsiella pneumoniae 53 90.57 100 100 99.5 58.49 100 100 97.8 100
Morganella morganii 15 93.33 100 100 99.9 93.33 100 100 99.9 100
Proteus mirabilis 75 98.67 100 100 99.9 96 100 100 99.7 100
Pseudomonas aeruginosa 120 99.17 100 100 99.9 97.5 100 100 99.7 99.1
Serratia marcescens 23 95.65 100 100 99.9 86.96 100 100 99.7 95.6
Stenotrophomonas
maltophilia
33 96.97 100 100 99.9 93.94 100 100 99.8 100
In parentheses: confidence level of identification. For details see text.
doi:10.1371/journal.pone.0016424.t002
Table 3. AI between MALDI-TOF MS and conventional methods for isolates of Gardnerella spp., Enterococcus spp. and
Streptococcus spp.
Taxon N Identical ID MALDI-TOF MS – conventional methods %AI
Gardnerella spp. 76 74 97.4
Enterococcus spp.*
E. casselliflavus
E. faecalis
E. faecium
E. gallinarum
50
1
21
19
9
44
0
21
19
4
88
0
100
100
44.4
Streptococcus spp.*
S. agalactiae
S. pneumoniae
Others
76
18
30
28
60
16
24
20
78.9
88.9
80
71.4
For Streptococcus and Enterococcus, 16S sequencing was used as the constructed gold standard.
*16S sequencing ID.
doi:10.1371/journal.pone.0016424.t003
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establishing a local database for both genera, to define new
SuperSpectra that should allow rapid and more reliable identifica-
tion of local isolates belonging to this variable taxonomic group.
Dubois et al. [9] have already shown that MALDI-TOF MS is a
powerful and reliable method to identify Staphylococcus species.
Most Staphylococcus species are correctly identified by MALDI-TOF
MS with a high level (.90%) of confidence. According to
Bernardo et al. [10] MALDI-TOF MS can be used for rapid
identification of clonal strains of S. aureus; we are currently
investigating the possibility of exploiting this feature to track
nosocomial or community acquired methicillin resistant S. aureus
strains. We cannot exclude that in the near future MALDI-TOF
MS may allow discriminating methicillin resistant from sensitive
Staphylococcus isolates, as suggested by some authors [11,12], but,
probably because of the polyphyletic nature of this resistance [13],
we have not yet achieved a robust typing at this level.
This is the first study that has tried to quantify the efficiency of
MALDI-TOF MS as compared to currently used methods. We
also used a mass spectrometer and a database different from that
described in previous publications and we found an almost perfect
concordance of our results with those so far reported in the
literature. We have been able to show that MALDI-TOF MS
represents a rapid, reliable and cost-effective identification
technique for clinically relevant bacteria. The method, however,
has some limitations. Reliable identification of organisms by this
technique is possible only if the spectral database contains data
from strains that have been carefully characterised by sequencing
specific and informative gene regions (e.g. 16S RNA, gyrB, rpoB,
or hsp60 genes for bacteria and ITS regions for fungi). Calibration
and selection of internal standards is needed when the work aims
at intraspecific characterization. Finally, for a conclusive analysis
of region specific strains, careful internal calibration and
preparation of locally adapted databases should be considered
when geographic variation in the genotypic and phenotypic
expression of some taxa (e.g., Streptococcus or Staphylococcus)i s
expected.
Overall, MALDI-TOF has found a well-deserved place in
bacterial taxonomy. Problems related to the analysis of mixed
cultures, presently not yet fully solved, are likely to be overcome in
the near future, and attempts to identify pathogens directly in the
clinical samples have already yielded promising results [14].
Susceptibility testing of fungi and bacteria by MALDI-TOF may
also be soon possible [15]. MALDI-TOF MS may thus become
the method of choice for the identification of clinically and
environmentally relevant organisms.
Materials and Methods
Isolates examined
Bacterial isolates were received during a three-month period
from our bacteriological routine laboratory. Isolates were collected
in sequential order and no selection criterion was applied to their
choice. In a first validation step we analysed 1,019 isolates
belonging to 27 bacterial genera (Table 1). Subsequently we
studied 202 additional isolates of Enterococcus, Gardnerella and
Streptococcus as well as 343 isolates that belonged to 17 Staphyloccoccus
species.
Isolates were cultured during 24–48 h at 35uC on 5% sheep
blood agar, chocolate agar, Mac Conkey agar, and Mueller
Hinton agar supplemented with 5% sheep blood (bioMe ´rieux,
Lyon, France). Growing colonies were checked for mixed cultures,
transferred to a new plate and the isolates growing in pure culture
were subsequently conserved in 7% skimmed milk at 280uC until
use.
Identification by biochemical methods and sequencing
Biochemical methods. After Gram staining and
determination of catalase and oxidase activities, isolates were
identified using PHOENIXH identification cards (BD Diagnostics,
Sparks, MD, USA) or APIH identification strips (bioMe ´rieux,
Lyon, France), both according to the manufacturer’s instructions.
We also used Slidex Staph Plus (bioMe ´rieux, Lyon, France) for
Staphylococcus aureus identification. Haemolytic streptococci were
identified based on the combination of colony morphology, Gram
staining and rapid latex agglutination test (Streptex; Remel,
Lenexa, KS).
Sequence data. Isolates that yielded discrepant results
between routine and MALDI-TOF MS identifications were
subjected to partial 16S rRNA gene sequencing. Unequivocal
identification was defined as the highest sequence homology (99%)
with a unique species sequence in GenBank.
DNA extraction was performed with the QIAamp DNA Mini
kit (QIAGEN AG, Switzerland) according to the manufacturer’s
instructions.
Primers used for the amplification of the partial 16S rRNA gene
sequence were UNI16SRNA-L (nucleotide sequence 59-ATTCT-
TAGAGTTTGATCATGGCTCA-39) and UNI16SRNA-R (nu-
cleotide sequence 59-ATGGTACCGTGTGACGGGCGGTG-
TGTA-39), which allowed the amplification of a 1400 bp DNA
fragment [16,17].
PCR thermal cycling conditions were 5 min at 95uC for 1 cycle,
followed by 35 cycles of 30 sec at 94uC, 30 sec at 52uC, and 1 min
at 72uC. The last cycle was performed at 72uC and lasted 10 min.
DNA purification was performed using NucleoSpinH (Cat.
No. 740609.250) according to the instructions for direct purifica-
tion of PCR products. We quantified the amplified and purified
DNA fragments before the sequencing reaction using a NANO
DROPH ND-1000 spectrophotometer (Thermo Fisher Scientific,
Houston, USA).
Sequencing reactions were carried out using Big DyeH
Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems,
Rotkreuz, Switzerland) with a 15 ml total volume composed of 2 ml
Big DyeHTerminator, 3 ml Big DyeHbuffer, 3 ml primer 1 mM, 6 ml
H2O and 1 ml DNA sample.
For the sequencing reaction the amplification cycle was 10 sec
at 96uC, 5 sec at 50uC, and 4 min at 60uC. Sequence reactions
were purified by Sephadex G-25 (Amersham Biosciences,
Otelfingen, Switzerland) before sequencing on an ABI 310
Genetic Analyzer (Perkin Elmer Instrument, Applied Biosystems,
Rotkreuz, Switzerland).
MALDI-TOF MS
All samples were analyzed with a MALDI-TOF MS Axima
TM
Confidence spectrometer (Shimadzu-Biotech Corp., Kyoto, Japan)
in positive linear mode (m/z=2,000–20,000). A small amount of a
Table 4. Sensitivity, specificity, PPV and NPV for Streptococcus
agalactiae and S. pneumoniae.
Sensitivity Specificity PPV NPV
S. agalactiae 100 96.7 88.9 100
S. pneumoniae 89 87.75 80 93.48
The study sample on which the calculation is based was represented by
Streptococcus spp. only.
doi:10.1371/journal.pone.0016424.t004
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doi:10.1371/journal.pone.0016424.g003
Figure 2. Efficiency of different methods for the identification of four Staphylococcus species as compared to 16S sequencing.
doi:10.1371/journal.pone.0016424.g002
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TM
target well using a disposable loop, overlaid with 0.5 ml of 2,5-
dihydroxybenzoic acid matrix solution (DHB; 10 mg/ml in
acetonitrile/0.1% trifluoroacetic acid 1:1) and air-dehydrated
within 1–2 min at 24–27uC.
The reference strain Escherichia coli K12 (genotype GM48) was
used as a standard for calibration and as reference for quality
control. Sample information such as medium and grown
conditions was imported into the software Shimadzu Biotech
Launchpad
TM, v.2.8 (Shimadzu-Biotech Corp., Kyoto, Japan).
Protein mass profiles were obtained with detection in the linear
positive mode at a laser frequency of 50 Hz and within a mass
range from 2,000–20,000 Da. Acceleration voltage was 20 kV and
extraction delay time 200 ns. A minimum of 20 laser shots per
sample was used to generate each ion spectrum. For each bacterial
sample, 50 protein mass fingerprints were averaged and processed.
Spectra were analyzed using SARAMIS
TM (Spectral Archive And
Microbial Identification System, AnagnosTec GmbH, Potzdam,
Germany), a software in which the identification at the species
level is based on a percentage of confidence referred to reference
spectra (SuperSpectra
TM) that contain family, genus and species
specific m/z biomarkers, as described in the SARAMIS
TM user
manual.
Data analysis
Genetic data were analyzed using the software ABI Prism
TM
310 Collection Genetic Analyser (Applied Biosystems, Rotk-
reuz, Switzerland). Alignments were performed using the
BioNumerics software v.6.01 (Applied Maths, Sint-Martens-
Latem, Belgium). The modular microorganism identification
system AnagnosTec SARAMIS
TM was used to archive and
evaluate MALDI-TOF MS data. SARAMIS
TM was also used to
construct dendrograms to show taxonomic relationships among
strains.
Agreement of identification (AI) between MALDI and
classical methods (APIH,P H O E N I X H)w a sd e f i n e da st h e
identical outcome of identification of a given isolate by all three
methods. Percentage of agreement between identifications
(AI%) was computed to compare the agreement of the
MALDI-TOF MS identifications with those of the classical
methods. 16S rRNA gene sequencing was used as a constructed
gold standard only in those cases when a discordant result was
observed.
When appropriate, we calculated the estimated sensitivity and
specificity and the 95% confidence intervals (CI), as well as the
positive predictive (PPV) and negative predictive (NPV) values
compared to the constructed perfect standard, corresponding to
the identification by 16S gene sequences. We calculated the
estimated sensitivity and specificity by defining a positive
identification by MALDI-TOF MS when the identification score
was at least $90%. Sensitivity, specificity and efficiency were
computed using DAG_Stat [18].
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Figure 4. Specificity of different methods for the identification of four Staphylococcus species as compared to 16S sequencing.
doi:10.1371/journal.pone.0016424.g004
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